glaucomaНациональный журнал ГлаукомаNational Journal glaucoma2078-41042311-6862Federal State Budgetary Institution of Science “Krasnov Research Institute of Eye Diseases”10.53432/2078-4104-2021-20-3-102-108glaucoma-347Research ArticleОБЗОР ЛИТЕРАТУРЫREVIEW OF LITERATUREОбщеофтальмологические вопросы коронавирусной инфекцииGeneral ophthalmological aspects of the COVID-19 infectionАбдуллаеваЭ. Х.AbdullaevaE. Kh.

  Абдуллаева Элиза Хосровна, врач-офтальмолог, аспирант

 119021,  Москва, ул. Россолимо, 11А 

 Ophthalmologist, postgraduate student

 11A Rossolimo St., Moscow,  119021 

eliza.abdullaeva0506@gmail.comФГБНУ «НИИ глазных болезней»РоссияResearch Institute of Eye DiseasesRussian Federation202120092021203102108Copyright © Абдуллаева Э.Х., 20212021Абдуллаева Э.Х.Abdullaeva E.K.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.glaucomajournal.ru/jour/article/view/347

Пандемия COVID-19 вошла в историю как чрезвычайная ситуация международного масштаба, повлекшая за собой смерть миллионов людей. Коронавирусная инфекция ставит перед медицинской наукой и, в частности, офтальмологией большое количество вопросов, по большей части не имеющих очевидных решений. Из-за недостаточной изученности проблемы коронавирусной инфекции в офтальмологии отсутствует полное понимание глазной симптоматики, методов профилактики, лечения и организации помощи таким пациентам в условиях пандемии. На основании исследований, выполненных с целью изучения данного вопроса, предполагается возможным непосредственное воздействие вируса на ткани поверхности глаза (конъюнктиву, роговицу). Также не исключается вероятность передачи инфекции через глазную поверхность. Эти данные указывают на необходимость расширять разрабатываемые меры профилактики распространения коронавирусной инфекции, в том числе через поверхность глаза.

The COVID-19 pandemic has gone down in history as an international emergency that resulted in the death of millions of people. The coronavirus infection poses a large number of problems for medical science and, in particular, ophthalmology, which for the most part do not have obvious solutions. Due to insufficient knowledge about coronavirus infection in ophthalmology, there is a lack of understanding of eye symptoms, methods of prevention, treatment and organization of healthcare for such patients during a pandemic. Based on the available studies researching these issues, it is assumed that the virus may directly affect the ocular surface tissues (conjunctiva, cornea). Also, the possibility of transmission of infection through the ocular surface has not been ruled out. The data indicate the need to expand the measures for prevention of the spread of coronavirus infection, including through the surface of the eye.

офтальмологиякоронавирускоронавирусная инфекцияophthalmologyCOVID-19coronavirus infectionReferencesHabibzadeh P., Stoneman E.K. The novel coronavirus: a bird's eye view. Int J Occup Environ Med. 2020; 11(2): 65–71. doi:10.15171/ijoem.2020.1921Habibzadeh P., Stoneman E.K. The novel coronavirus: a bird's eye view. Int J Occup Environ Med. 2020; 11(2): 65–71. doi:10.15171/ijoem.2020.1921Su S., Wong G., Shi W., Liu J., Lai A.C.K., Zhou J., Liu W., Bi Y., Gao G.F. Epidemiology, genetic recombination, and pathogenesis of coronaviruses. Trends Microbiol. 2016; 24(6):490–502. doi:10.1016/j.tim.2016.03.003Su S., Wong G., Shi W., Liu J., Lai A.C.K., Zhou J., Liu W., Bi Y., Gao G.F. Epidemiology, genetic recombination, and pathogenesis of coronaviruses. Trends Microbiol. 2016; 24(6):490–502. doi:10.1016/j.tim.2016.03.003Cui J., Li F., Shi Z.L. Origin and evolution of pathogenic coronaviruses. Nat Rev Microbiol. 2019; 17:181-192.Cui J., Li F., Shi Z.L. Origin and evolution of pathogenic coronaviruses. Nat Rev Microbiol. 2019; 17:181-192.Chan J.F., Yuan S., Kok K.H. et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating personto-person transmission: a study of a family cluster. Lancet. 2020. doi:10.1016/S0140-6736(20)30154-9Chan J.F., Yuan S., Kok K.H. et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating personto-person transmission: a study of a family cluster. Lancet. 2020. doi:10.1016/S0140-6736(20)30154-9Report of the WHO-China Joint Mission on Coronavirus Disease 2019 (COVID-19). 16-24 February 2020. World Health Organization; 2020. Available from: https://www.who.int/docs/default-source/coronaviruse/who-china-joint-mission-on-covid-19-final-report.pdf [Accessed 26 June 2020]Report of the WHO-China Joint Mission on Coronavirus Disease 2019 (COVID-19). 16-24 February 2020. World Health Organization; 2020. Available from: https://www.who.int/docs/default-source/coronaviruse/who-china-joint-mission-on-covid-19-final-report.pdf [Accessed 26 June 2020]Lukassen S., Chua R.L., Trefzer T., Kahn N.C., Schneider M.A., Muley T. et al. SARS-CoV-2 receptor ACE2 and TMPRSS2 are primarily expressed in bronchial transient secretory cells. The EMBO J. 2020: e105114.Lukassen S., Chua R.L., Trefzer T., Kahn N.C., Schneider M.A., Muley T. et al. SARS-CoV-2 receptor ACE2 and TMPRSS2 are primarily expressed in bronchial transient secretory cells. The EMBO J. 2020:e105114.Ou X., Liu Y., Lei X. et al. Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV. Nat Commun. 2020; 11(1):1620. doi:10.1038/s41467-020-15562-9Ou X., Liu Y., Lei X. et al. Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV. Nat Commun. 2020; 11(1):1620. doi:10.1038/s41467-020-15562-9D'Elia R.V., Harrison K., Oyston P.C., Lukaszewski R.A., Clark G.C. Targeting the "cytokine storm" for therapeutic benefit. Clin Vaccine Immunol. 2013; 237(20):319-327. doi:10.1128/cvi.00636-12D'Elia R.V., Harrison K., Oyston P.C., Lukaszewski R.A., Clark G.C. Targeting the "cytokine storm" for therapeutic benefit. Clin Vaccine Immunol. 2013; 237(20):319-327. doi:10.1128/cvi.00636-12Ben Salem C. Acute respiratory distress syndrome. N Engl J Med. 2017; 377(19):1904. doi:10.1056/NEJMc1711824Ben Salem C. Acute respiratory distress syndrome. N Engl J Med. 2017; 377(19):1904. doi:10.1056/NEJMc1711824Yang Y. et al. Exuberant elevation of IP-10, MCP-3 and IL-1ra during SARS-CoV-2 infection is associated with disease severity and fatal outcome. Preprint at medRxiv. https://doi.org/10.1101/2020.03.02.20029975 (2020)Yang Y. et al. Exuberant elevation of IP-10, MCP-3 and IL-1ra during SARS-CoV-2 infection is associated with disease severity and fatal outcome. Preprint at medRxiv. https://doi.org/10.1101/2020.03.02.20029975 (2020)Wan S., Yi Q., Fan S., Lv J., Zhang X., Guo L., Lang C., Xiao Q., Xiao K., Yi Z., Qiang M., Xiang J., Zhang B., Chen Y., Gao C. Relationships among lymphocyte subsets, cytokines, and the pulmonary inflammation index in coronavirus (COVID-19) infected patients. Br J Haematol. 2020; 189:428-437. https://doi.org/10.1111/bjh.16659Wan S., Yi Q., Fan S., Lv J., Zhang X., Guo L., Lang C., Xiao Q., Xiao K., Yi Z., Qiang M., Xiang J., Zhang B., Chen Y., Gao C. Relationships among lymphocyte subsets, cytokines, and the pulmonary inflammation index in coronavirus (COVID-19) infected patients. Br J Haematol. 2020; 189:428-437. https://doi.org/10.1111/bjh.16659Liu J., Li S., Liu J., Liang B., Wang X., Wang H. et al. Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2 infected patients. MedRxiv. 2020.02.16.20023671Liu J., Li S., Liu J., Liang B., Wang X., Wang H. et al. Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2 infected patients. MedRxiv. 2020.02.16.20023671Tufan A., Avanoğlu Güler A., Matucci-Cerinic M. COVID-19, immune system response, hyperinflammation and repurposing antirheumatic drugs. Turkish J Med Sci. 2020; 50(SI-1):620–632.Tufan A., Avanoğlu Güler A., Matucci-Cerinic M. COVID-19, immune system response, hyperinflammation and repurposing antirheumatic drugs. Turkish J Med Sci. 2020; 50(SI-1):620–632.Wu D., Yang X.O., TH17 responses in cytokine storm of COVID-19: An emerging target of JAK2 inhibitor Fedratinib [published online ahead of print, 2020 Mar 11]. J Microbiol Immunol Infect. 2020; 53(3):368–370 doi.org/10.1016/j.jmii.2020.03.005Wu D., Yang X.O., TH17 responses in cytokine storm of COVID-19: An emerging target of JAK2 inhibitor Fedratinib [published online ahead of print, 2020 Mar 11]. J Microbiol Immunol Infect. 2020; 53(3):368–370 doi.org/10.1016/j.jmii.2020.03.005Yazdanpanah Fereshteh, Hamblin Michael R., Rezaei Nima. The immune system and COVID-19: Friend or foe? Life Sci. 2020; 256: 117900. doi: 10.1016/j.lfs.2020.117900Yazdanpanah Fereshteh, Hamblin Michael R., Rezaei Nima. The immune system and COVID-19: Friend or foe? Life Sci. 2020; 256: 117900. doi: 10.1016/j.lfs.2020.117900Zhou L., Xu Z., Castiglione G.M., Soiberman U.S., Eberhart C.G., Duh E.J. ACE2 and TMPRSS2 are expressed on the human ocular surface, suggesting susceptibility to SARS-CoV-2 infection. Ocul Surf. 2020; 18(4): 537–544. doi:10.1016/j.jtos.2020.06.007Zhou L., Xu Z., Castiglione G.M., Soiberman U.S., Eberhart C.G., Duh E.J. ACE2 and TMPRSS2 are expressed on the human ocular surface, suggesting susceptibility to SARS-CoV-2 infection. Ocul Surf. 2020; 18(4): 537–544. doi:10.1016/j.jtos.2020.06.007Xia J., Tong J., Liu M., Shen Y., Guo D. Evaluation of coronavirus in tears and conjunctival secretions of patients with SARS-CoV-2 infection. J Med Virol. 2020; 92(6):589–594. doi:10.1002/jmv.25725Xia J., Tong J., Liu M., Shen Y., Guo D. Evaluation of coronavirus in tears and conjunctival secretions of patients with SARS-CoV-2 infection. J Med Virol. 2020; 92(6):589–594. doi:10.1002/jmv.25725Raj V.S., Mou H., Smits S.L., Dekkers D.H., Müller M.A., Dijkman R., Muth D., Demmers J.A., Zaki A., Fouchier R.A., Thiel V., Drosten C., Rottier P.J., Osterhaus A.D., Bosch B.J., Haagmans B.L. Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC. Nature. 2013; 495(7440):251-254. doi:10.1038/nature12005Raj V.S., Mou H., Smits S.L., Dekkers D.H., Müller M.A., Dijkman R., Muth D., Demmers J.A., Zaki A., Fouchier R.A., Thiel V., Drosten C., Rottier P.J., Osterhaus A.D., Bosch B.J., Haagmans B.L. Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC. Nature. 2013; 495(7440):251-254. doi:10.1038/nature12005Loon S.-C., Teoh S.C.B., Oon L.L.E. et al. The severe acute respiratory syndrome coronavirus in tears. Br J Ophthalmol. 2004; 88(7): 861–863. doi:10.1136/bjo.2003.035931Loon S.-C., Teoh S.C.B., Oon L.L.E. et al. The severe acute respiratory syndrome coronavirus in tears. Br J Ophthalmol. 2004; 88(7): 861–863. doi:10.1136/bjo.2003.035931Lu R., Zhao X., Li J. et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet. 2020. doi: 10.1016/S0140-6736(20)30251-8Lu R., Zhao X., Li J. et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet. 2020. doi: 10.1016/S0140-6736(20)30251-8Tong T., Lai T.S. The severe acute respiratory syndrome coronavirus in tears. Br J Ophthalmol. 2005; 89(3):392. doi:10.1136/bjo.2004.054130Tong T., Lai T.S. The severe acute respiratory syndrome coronavirus in tears. Br J Ophthalmol. 2005; 89(3):392. doi:10.1136/bjo.2004.054130Chan W.M., Yuen K.S., Fan D.S., Lam D.S., Chan P.K., Sung J.J. Tears and conjunctival scrapings for coronavirus in patients with SARS. Br J Ophthalmol. 2004; 88(7): 968–969. doi:10.1136/bjo.2003.039461Chan W.M., Yuen K.S., Fan D.S., Lam D.S., Chan P.K., Sung J.J. Tears and conjunctival scrapings for coronavirus in patients with SARS. Br J Ophthalmol. 2004; 88(7): 968–969. doi:10.1136/bjo.2003.039461Seah I., Agrawal R. Can the coronavirus disease 2019 (COVID-19) Affect the Eyes? A review of coronaviruses and ocular implications in humans and animals. Ocul Immunol Inflamm. 2020; 28(3):391-395. doi:10.1080/09273948.2020.1738501Seah I., Agrawal R. Can the coronavirus disease 2019 (COVID-19) Affect the Eyes? A review of coronaviruses and ocular implications in humans and animals. Ocul Immunol Inflamm. 2020; 28(3):391-395. doi:10.1080/09273948.2020.1738501Raboud J., Shigayeva A., McGeer A. et al. Risk factors for SARS transmission from patients requiring intubation: a multicentre investigation in Toronto, Canada. PLoS One. 2010; 5(5):e10717.Raboud J., Shigayeva A., McGeer A. et al. Risk factors for SARS transmission from patients requiring intubation: a multicentre investigation in Toronto, Canada. PLoS One. 2010; 5(5):e10717.Wu P., Duan F., Luo C. et al. Characteristics of ocular findings of patients with coronavirus disease 2019 (COVID-19) in Hubei province, China. JAMA Ophthalmol. 2020; 138(5):575-578. doi:10.1001/jamaophthalmol.2020.1291Wu P., Duan F., Luo C. et al. Characteristics of ocular findings of patients with coronavirus disease 2019 (COVID-19) in Hubei province, China. JAMA Ophthalmol. 2020; 138(5):575-578. doi:10.1001/jamaophthalmol.2020.1291Loffredo L., Pacella F., Pacella E., Tiscione G., Oliva A., Violi F. Conjunctivitis and COVID-19: a meta-analysis. J Med Virol. 2020; 92(9):1413-1414. doi: 10.1002/jmv.25938Loffredo L., Pacella F., Pacella E., Tiscione G., Oliva A., Violi F. Conjunctivitis and COVID-19: a meta-analysis. J Med Virol. 2020; 92(9):1413-1414. doi: 10.1002/jmv.25938Hu Y., Chen T., Liu M., Zhang L., Wang F., Zhao S., Liu H., Xia H., Wang Y., Li L. Positive detection of SARS-CoV-2 combined HSV1 and HHV6B virus nucleic acid in tear and conjunctival secretions of a nonconjunctivitis COVID-19 patient with obstruction of common lacrimal duct. Acta Ophthalmol. 2020; 98:859-863. https://doi.org/10.1111/aos.14456Hu Y., Chen T., Liu M., Zhang L., Wang F., Zhao S., Liu H., Xia H., Wang Y., Li L. Positive detection of SARS-CoV-2 combined HSV1 and HHV6B virus nucleic acid in tear and conjunctival secretions of a nonconjunctivitis COVID-19 patient with obstruction of common lacrimal duct. Acta Ophthalmol. 2020; 98:859-863. https://doi.org/10.1111/aos.14456Dockery D.M., Rowe S.G., Murphy M.A., Krzystolik M.G. The ocular manifestations and transmission of COVID-19: recommendations for prevention. J Emerg Med. 2020; S0736-4679(20):30398-X. doi:10.1016/j.jemermed.2020.04.060Dockery D.M., Rowe S.G., Murphy M.A., Krzystolik M.G. The ocular manifestations and transmission of COVID-19: recommendations for prevention. J Emerg Med. 2020; S0736-4679(20):30398-X. doi:10.1016/j.jemermed.2020.04.060Mukamal R., Tuli S.S. Coronavirus eye safety. American Academy of Ophthalmology (AAO). 2020. Available at https://www.aao.org/eye-health/tips-prevention/coronavirus-covid19-eye-infectionpinkeye. Accessed April 26, 2020Mukamal R., Tuli S.S. Coronavirus eye safety. American Academy of Ophthalmology (AAO). 2020. Available at https://www.aao.org/eye-health/tips-prevention/coronavirus-covid19-eye-infectionpinkeye. Accessed April 26, 2020Chodosh J., Holland G.N., Yeh S. Important coronavirus updates for ophthalmologists. American Academy of Ophthalmology. 2020. Available at: https://www.aao.org/headline/alertimportant-coronaviruscontext. Accessed May 5, 2020Chodosh J., Holland G.N., Yeh S. Important coronavirus updates for ophthalmologists. American Academy of Ophthalmology. 2020. Available at: https://www.aao.org/headline/alertimportant-coronaviruscontext. Accessed May 5, 2020

The authors declare that there are no conflicts of interest present.